Piramal Pharma (NSE:PPLPHARMA) Construction In Progress : ₹5,657 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Construction In Progress?

Piramal Pharma's quarterly construction in progress declined from Sep. 2023 (₹9,888 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹5,657 Mil).

Piramal Pharma's annual construction in progress increased from Mar. 2022 (₹6,732 Mil) to Mar. 2023 (₹8,529 Mil) but then declined from Mar. 2023 (₹8,529 Mil) to Mar. 2024 (₹5,657 Mil).

Piramal Pharma Construction In Progress Historical Data

The historical data trend for Piramal Pharma's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Construction In Progress Chart

Piramal Pharma Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Construction In Progress

793.40

6,731.50

8,529.30

5,657.00

Piramal Pharma Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial							8,529.30	-	9,887.60	-	5,657.00

Piramal Pharma Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Piramal Pharma (NSE:PPLPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » Construction In Progress

Traded in Other Exchanges

543635:India

Address

Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070

Website

https://www.piramal.com

Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (NSE:PPLPHARMA) Headlines

No Headlines